coronary heart disease
Conditions
Interventions
Study Group:Western medicine basic treatment + ascending depression and stasis removal of turbidity granule group
Control group:Western medicine basic treatment + ascending depression and stasis and turbidity granules placebo group
Coronary heart disease phlegm turbidity and blood stasis syndrome group:None
Coronary Heart Disease Qi Deficiency Phlegm Stasis Syndrome Group:None
Healthy individuals with peaceful quality group:None
Sponsors
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18~75 years old; (2) Patients with angina pectoris with coronary heart disease, with typical angina symptoms or equivalent symptoms, angina CCS grade I to III; (3) TCM syndrome differentiation is phlegm turbidity blood stasis pattern, qi deficiency phlegm stasis pattern; (4) Those who voluntarily sign a written informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with acute myocardial infarction, pulmonary embolism and acute cerebrovascular disease within 3 months before enrollment; (2) Patients with severe heart failure (cardiac function grade III-IV), malignant arrhythmia and other heart diseases: valvular heart disease, heart dilatation disease, hyperheart disease, pulmonary heart disease, atrial fibrillation, etc.; (3) Those with poor control of hypertension and diabetes after adjusting treatment; (4) Patients with severe liver and kidney diseases or cachexia in the terminal stage of malignant tumors; (5) Patients with active tuberculosis or rheumatic immune diseases; (6) Patients with hematological diseases, organ transplantation and uremia; (7) Those who are mentally ill and have poor disease control and drug addicts who have not recovered from drugs; (8) Those who participated in other research projects in the past 1 month; (9) Pregnant or lactating females;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiopulmonary exercise peak metabolic equivalent; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the efficacy of TCM syndromes;Seattle Angina Scale;Cardiopulmonary exercise test;Incidence of MACE; | — |
Countries
China
Contacts
Public Contactyongxia Wang
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Outcome results
None listed